Kramer W, Stengelin S, Baringhaus K H, Enhsen A, Heuer H, Becker W, Corsiero D, Girbig F, Noll R, Weyland C
DG Metabolic Diseases, Hoechst Marion Roussel Deutschland GmbH, D-65926 Frankfurt am Main, Germany.
J Lipid Res. 1999 Sep;40(9):1604-17.
The substrate specificity of the ileal and the hepatic Na(+)/bile acid cotransporters was determined using brush border membrane vesicles and CHO cell lines permanently expressing the Na(+)/bile acid cotransporters from rabbit ileum or rabbit liver. The hepatic transporter showed a remarkably broad specificity for interaction with cholephilic compounds in contrast to the ileal system. The anion transport inhibitor diisothiocyanostilbene disulfonate (DIDS) is a strong inhibitor of the hepatic Na(+)/bile acid cotransporter, but does not show any affinity to its ileal counterpart. Inhibition studies and uptake measurements with about 40 different bile acid analogues differing in the number, position, and stereochemistry of the hydroxyl groups at the steroid nucleus resulted in clear structure;-activity relationships for the ileal and hepatic bile acid transporters. The affinity to the ileal and hepatic Na(+)/bile acid cotransport systems and the uptake rates by cell lines expressing those transporters as well as rabbit ileal brush border membrane vesicles is primarily determined by the substituents on the steroid nucleus. Two hydroxy groups at position 3, 7, or 12 are optimal whereas the presence of three hydroxy groups decreased affinity. Vicinal hydroxy groups at positions 6 and 7 or a shift of the 7-hydroxy group to the 6-position significantly decreased the affinity to the ileal transporter in contrast to the hepatic system. 6-Hydroxylated bile acid derivatives are preferred substrates of the hepatic Na(+)/bile acid cotransporter. Surprisingly, the 3alpha-hydroxy group being present in all natural bile acids is not essential for high affinity interaction with the ileal and the hepatic bile acid transporter. The 3alpha-hydroxy group seems to be necessary for optimal transport of a bile acid across the hepatocyte canalicular membrane. A modification of bile acids at the 3-position therefore conserves the bile acid character thus determining the 3-position of bile acids as the ideal position for drug targeting strategies using bile acid transport pathways.
利用刷状缘膜囊泡和稳定表达兔回肠或兔肝脏Na⁺/胆汁酸共转运蛋白的CHO细胞系,测定了回肠和肝脏Na⁺/胆汁酸共转运蛋白的底物特异性。与回肠系统相比,肝脏转运蛋白对亲胆化合物的相互作用表现出显著更广泛的特异性。阴离子转运抑制剂二异硫氰酸苯乙烯二磺酸盐(DIDS)是肝脏Na⁺/胆汁酸共转运蛋白的强效抑制剂,但对其回肠对应物没有任何亲和力。对约40种在甾体核上羟基的数量、位置和立体化学不同的胆汁酸类似物进行抑制研究和摄取测量,得出了回肠和肝脏胆汁酸转运蛋白明确的构效关系。对回肠和肝脏Na⁺/胆汁酸共转运系统的亲和力以及表达这些转运蛋白的细胞系和兔回肠刷状缘膜囊泡的摄取速率主要由甾体核上的取代基决定。3、7或位置12处的两个羟基是最佳的,而三个羟基的存在会降低亲和力。与肝脏系统相比,6和7位的邻位羟基或7-羟基向6位的移动会显著降低对回肠转运蛋白的亲和力。6-羟基化胆汁酸衍生物是肝脏Na⁺/胆汁酸共转运蛋白的优选底物。令人惊讶的是,所有天然胆汁酸中都存在的3α-羟基对于与回肠和肝脏胆汁酸转运蛋白的高亲和力相互作用并非必需。3α-羟基似乎是胆汁酸跨肝细胞胆小管膜最佳转运所必需的。因此,胆汁酸在3位的修饰保留了胆汁酸的特性,从而将胆汁酸的3位确定为利用胆汁酸转运途径进行药物靶向策略的理想位置。